By continuing to browse the site you are agreeing to our use of cookies.
Find out more here.
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Find out more here.
Cyprotex was acquired by Evotec AG in December 2016. The Investor Relations section has now been removed from the Cyprotex website. Please refer to the Evotec website for future Investor Relations updates.
Telephone:
Europe: +44 (0)1625 505100
North America (East Coast): +1-888-297-7683
Email:
info@evotec.eu